Ozurdex® in Patients With Non-infectious Uveitis Affecting the Posterior Segment of the Eye (Louvre 2)

Allergan

Status: Terminated

Conditions: Non-infectious Uveitis

Treatments: Drug: dexamethasone intravitreal implant

Study type: Observational

Funder types: Industry

Identifiers

NCT02951975

GMA-EAME-EYE-0368

Details and patient eligibility

About

This observational study will evaluate the safety, efficacy, characteristics of patients, characteristics of physicians and quality of life in patients who are prescribed OZURDEX® as treatment for non-infectious uveitis of the posterior segment of the eye in France.

Enrollment: 246 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

-Patient with non-infectious uveitis affecting the posterior segment of the eye.

Exclusion criteria

-Patient not residing in metropolitan France.

Trial design

246 participants in 1 patient group

OZURDEX®

Description:

Patients prescribed dexamethasone intravitreal implant (OZURDEX®) in clinical practice for the treatment of non-infectious uveitis affecting the posterior segment of the eye.

Treatment:

Drug: dexamethasone intravitreal implant